Two terphenyl‐based diol hosts and corresponding solvent inclusions with dimethylformamide and acetonitrile

Having reference to an elongated structural modification of 2,2′‐bis(hydroxydiphenylmethyl)biphenyl, (I), the two 1,1′:4′,1′′‐terphenyl‐based diol hosts 2,2′′‐bis(hydroxydiphenylmethyl)‐1,1′:4′,1′′‐terphenyl, C₄₄H₃₄O₂, (II), and 2,2′′‐bis[hydroxybis(4‐methylphenyl)methyl]‐1,1′:4′,1′′‐terphenyl, C₄₈H₄₂O₂, (III), have been synthesized and studied with regard to their crystal structures involving different inclusions, i.e. (II) with dimethylformamide (DMF), C₄₄H₃₄O₂·C₂H₆NO, denoted (IIa), (III) with DMF, C₄₈H₄₂O₂·C₂H₆NO, denoted (IIIa), and (III) with acetonitrile, C₄₈H₄₂O₂·CH₃CN, denoted (IIIb). In the solvent‐free crystals of (II) and (III), the hydroxy H atoms are involved in intramolecular O—H...π hydrogen bonding, with the central arene ring of the terphenyl unit acting as an acceptor. The corresponding crystal structures are stabilized by intermolecular C—H...π contacts. Due to the distinctive acceptor character of the included DMF solvent species in the crystal structures of (IIa) and (IIIa), the guest molecule is coordinated to the host via O—H...O=C hydrogen bonding. In both crystal structures, infinite strands composed of alternating host and guest molecules represent the basic supramolecular aggregates. Within a given strand, the O atom of the solvent molecule acts as a bifurcated acceptor. Similar to the solvent‐free cases, the hydroxy H atoms in inclusion structure (IIIb) are involved in intramolecular hydrogen bonding, and there is thus a lack of host–guest interaction. As a result, the solvent molecules are accommodated as C—H...N hydrogen‐bonded inversion‐symmetric dimers in the channel‐like voids of the host lattice.     

Solvent influence on the crystal packing of 6‐aminothiocytosine

The crystal structures of 6‐aminothiocytosine (systematic name: 4,6‐diamino‐1,2‐dihydropyrimidine‐2‐thione, DAPMT, C₄H₆N₄S), its hemihydrate (0.5H₂O) and its dimethylformamide (DMF, C₃H₇NO) monosolvate were compared, and the influence of the type of solvent on the supramolecular motifs was analysed. In all three crystal structures, there are two symmetry‐independent molecules (A and B), and these molecules are connected by three relatively short and directional hydrogen bonds to form chains of alternating A and B molecules. A further organization of these chains is dependent on the nature of the solvent molecule. In the unsolvated form, two orientations of the neighbouring chains are observed, and similar motifs – but only one per structure – can be observed in the solvated structures. These two different motifs can be connected by two different kinds of contacts, i.e. either π–π (hemihydrate) or staple‐supported S…S (DMF). In the crystal structures, the O atoms of the solvent molecules are double acceptors of the same type of hydrogen bonds and bind the chains of DAPMT molecules into different motifs (dimeric or infinite chains). A Hirshfeld fingerprint analysis was used for visualization and additional interpretation of these results.     

Solvent‐mediated pseudo‐quadruple hydrogen‐bond motifs in three lamotrigine–carboxylic acid complexes

Lamotrigine, an antiepileptic drug, has been complexed with three aromatic carboxylic acids. All three compounds crystallize with the inclusion of N,N‐dimethylformamide (DMF) solvent, viz. lamotriginium [3,5‐diamino‐6‐(2,3‐dichlorophenyl)‐1,2,4‐triazin‐2‐ium] 4‐iodobenzoate N,N‐dimethylformamide monosolvate, C₉H₈Cl₂N₅⁺·C₇H₄IO₂⁻·C₃H₇NO, (I), lamotriginium 4‐methylbenzoate N,N‐dimethylformamide monosolvate, C₉H₇Cl₂N₅⁺·C₈H₈O₂⁻·C₃H₇NO, (II), and lamotriginium 3,5‐dinitro‐2‐hydroxybenzoate N,N‐dimethylformamide monosolvate, C₉H₈Cl₂N₅⁺·C₇H₃N₂O₇⁻·C₃H₇NO, (III). In all three structures, proton transfer takes place from the acid to the lamotrigine molecule. However, in (I) and (II), the acidic H atom is disordered over two sites and there is only partial transfer of the H atom from O to N. In (III), the corresponding H atom is ordered and complete proton transfer has occurred. Lamotrigine–lamotrigine, lamotrigine–acid and lamotrigine–solvent interactions are observed in all three structures and they thereby exhibit isostructurality. The DMF solvent extends the lamotrigine–lamotrigine dimers into a pseudo‐quadruple hydrogen‐bonding motif.     

Pseudopolymorphs of 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one: one or two tautomers present in the same crystal

The derivatives of pyrimidin‐4‐one can adopt either a 1H‐ or a 3H‐tautomeric form, which affects the hydrogen‐bonding interactions in cocrystals with compounds containing complementary functional groups. In order to study their tautomeric preferences, we crystallized 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one. During various crystallization attempts, four structures of 2,6‐diaminopyrimidin‐4‐one were obtained, namely solvent‐free 2,6‐diaminopyrimidin‐4‐one, C₄H₆N₄O, (I), 2,6‐diaminopyrimidin‐4‐one–dimethylformamide–water (3/4/1), C₄H₆N₄O·1.33C₃H₇NO·0.33H₂O, (Ia), 2,6‐diaminopyrimidin‐4‐one dimethylacetamide monosolvate, C₄H₆N₄O·C₄H₉NO, (Ib), and 2,6‐diaminopyrimidin‐4‐one–N‐methylpyrrolidin‐2‐one (3/2), C₄H₆N₄O·1.5C₅H₉NO, (Ic). The 2,6‐diaminopyrimidin‐4‐one molecules exist only as 3H‐tautomers. They form ribbons characterized by R²₂(8) hydrogen‐bonding interactions, which are further connected to form three‐dimensional networks. An intermolecular N—H...N interaction between amine groups is observed only in (I). This might be the reason for the pyramidalization of the amine group. Crystallization experiments on 2‐amino‐6‐methylpyrimidin‐4‐one yielded two isostructural pseudopolymorphs, namely 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–dimethylacetamide (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₄H₉NO, (IIa), and 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₅H₉NO, (IIb). In both structures, a 1:1 mixture of 1H‐ and 3H‐tautomers is present, which are linked by three hydrogen bonds similar to a Watson–Crick C–G base pair.     

Supramolecular aggregation in three 4‐aryl‐6‐(1H‐indol‐3‐yl)‐3‐methyl‐1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine‐5‐carbonitriles

Both 6‐(1H‐indol‐3‐yl)‐3‐methyl‐4‐(4‐methylphenyl)‐1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine‐5‐carbonitrile and 6‐(1H‐indol‐3‐yl)‐3‐methyl‐4‐(4‐methoxyphenyl)‐1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine‐5‐carbonitrile crystallize from dimethylformamide solutions as stoichiometric 1:1 solvates, viz. C₂₉H₂₁N₅·C₃H₇NO, (I), and C₂₉H₂₁N₅O·C₃H₇NO, (II), respectively; however, 6‐(1H‐indol‐3‐yl)‐3‐methyl‐1‐phenyl‐4‐(3,4,5‐trimethoxyphenyl)‐1H‐pyrazolo[3,4‐b]pyridine‐5‐carbonitrile, C₃₁H₂₅N₅O₃, (III), crystallizes in the unsolvated form. The heterocyclic components of (I) are linked by C—H...π(arene) hydrogen bonds to form cyclic centrosymmetric dimers, from which the solvent molecules are pendent, linked by N—H...O hydrogen bonds. In (II), the heterocyclic components are linked by a combination of C—H...N and C—H...π(arene) hydrogen bonds into chains containing two types of centrosymmetric ring, and the pendent solvent molecules are linked to these chains by N—H...O hydrogen bonds. Molecules of (III) are linked into simple C(12) chains by an N—H...O hydrogen bond, and these chains are weakly linked into pairs by an aromatic π–π stacking interaction.     

3‐Cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone: two new pseudopolymorphs and two cocrystals with products of an in situ nucleophilic aromatic substitution

Four crystal structures of 3‐cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone (CMP), viz. the dimethyl sulfoxide monosolvate, C₇H₆N₂O₂·C₂H₆OS, (1), the N,N‐dimethylacetamide monosolvate, C₇H₆N₂O₂·C₄H₉NO, (2), a cocrystal with 2‐amino‐4‐dimethylamino‐6‐methylpyrimidine (as the salt 2‐amino‐4‐dimethylamino‐6‐methylpyrimidin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate), C₇H₁₃N₄⁺·C₇H₅N₂O₂⁻, (3), and a cocrystal with N,N‐dimethylacetamide and 4,6‐diamino‐2‐dimethylamino‐1,3,5‐triazine [as the solvated salt 2,6‐diamino‐4‐dimethylamino‐1,3,5‐triazin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate–N,N‐dimethylacetamide (1/1)], C₅H₁₁N₆⁺·C₇H₅N₂O₂⁻·C₄H₉NO, (4), are reported. Solvates (1) and (2) both contain the hydroxy group in a para position with respect to the cyano group of CMP, acting as a hydrogen‐bond donor and leading to rather similar packing motifs. In cocrystals (3) and (4), hydrolysis of the solvent molecules occurs and an in situ nucleophilic aromatic substitution of a Cl atom with a dimethylamino group has taken place. Within all four structures, an R₂²(8) N—H...O hydrogen‐bonding pattern is observed, connecting the CMP molecules, but the pattern differs depending on which O atom participates in the motif, either the ortho or para O atom with respect to the cyano group. Solvents and coformers are attached to these arrangements via single‐point O—H...O interactions in (1) and (2) or by additional R₄⁴(16) hydrogen‐bonding patterns in (3) and (4). Since the in situ nucleophilic aromatic substitution of the coformers occurs, the possible Watson–Crick C–G base‐pair‐like arrangement is inhibited, yet the cyano group of the CMP molecules participates in hydrogen bonds with their coformers, influencing the crystal packing to form chains.     

7‐Amino‐2‐methylsulfanyl‐1,2,4‐triazolo[1,5‐a]pyrimidine‐6‐carboxylic acid as the dimethylformamide and water monosolvates at 293 K

The molecular structure of 7‐amino‐2‐methylsulfanyl‐1,2,4‐triazolo[1,5‐a]pyrimidine‐6‐carboxylic acid is reported in two crystal environments, viz. as the dimethylformamide (DMF) monosolvate, C₇H₇N₅O₂S·C₃H₇NO, (I), and as the monohydrate, C₇H₇N₅O₂S·H₂O, (II), both at 293 (2) K. The triazolo[1,5‐a]pyrimidine molecule is of interest with respect to the possible biological activity of its coordination compounds. While the DMF solvate exhibits a layered structural arrangement through N...O hydrogen‐bonding interactions, the monohydrate displays a network of intermolecular O...O and N...O hydrogen bonds assisted by cocrystallized water molecules and weak π–π stacking interactions, leading to a different three‐dimensional supramolecular architecture. Based on results from topological analyses of the electron‐density distribution in X—H...O (X = O, N and C) regions, hydrogen‐bonding energies have been estimated from structural information only, enabling the characterization of hydrogen‐bond graph energies.     

Three solvates of a bis‐mesoionic fluorescent yellow pigment

p‐Phenylenebis(2‐oxo‐3‐phenyl‐1,2‐dihydropyrido[1,2‐a]pyrimidin‐5‐ium‐4‐olate), C₃₄H₂₂N₄O₄, is a bis‐mesoionic yellow pigment that shows fluorescence in the solid state. During a polymorph screening, single crystals of three solvates were grown and their crystal structures determined. Solvent‐free crystals were not obtained. A solvate with N‐methylpyrrolidone (NMP) and propan‐2‐ol, C₃₄H₂₂N₄O₄·2C₅H₉NO·C₃H₈O, (Ia), and an NMP trisolvate, C₃₄H₂₂N₄O₄·3C₅H₉NO, (Ib), crystallize with pigment molecules on inversion centres. The NMP/propan‐2‐ol mixed solvate (Ia) forms O—H...O hydrogen bonds between the different solvent molecules. In both structures, at least one of the solvent molecules is disordered. A third solvate structure, C₃₄H₂₂N₄O₄·0.5C₅H₉NO·C₄H₁₀O, (Ic), was obtained by crystallization from NMP and butan‐1‐ol. In this case, there are two symmetry‐independent pigment molecules, both situated on inversion centres. The solvent molecules are heavily disordered and their contribution to the scattering was suppressed. This solvate displays a channel structure, whereas the other two solvates form layer structures.     

Two furan‐2,5‐dicarboxylic acid solvates crystallized from dimethylformamide and dimethyl sulfoxide

Furan‐2,5‐dicarboxylic acid (FDCA) has been ranked among the top 12 bio‐based building‐block chemicals by the Department of Energy in the US. The molecule was first synthesized in 1876, but large‐scale production has only become possible since the development of modern bio‐ and chemical catalysis techniques. The structures of two FDCA solvates, namely, FDCA dimethylformamide (DMF) disolvate, C₆H₄O₅·2C₃H₇NO, (I), and FDCA dimethyl sulfoxide (DMSO) monosolvate, C₆H₄O₅·C₂H₆OS, (II), are reported. Solvate (I) crystallizes in the orthorhombic Pbcn space group and solvate (II) crystallizes in the monoclinic P space group. In (I), hydrogen bonds form between the carbonyl O atom in DMF and a hydroxy H atom in FDCA. Whilst in (II), the O atom in one DMSO molecule hydrogen bonds with hydroxy H atoms in two FDCA molecules. Combined with intermolecular S…O interactions, FDCA molecules form a two‐dimensional network coordinated by DMSO.     

Disulfonated azo dyes: metal coordination and ion‐pair separation in twelve MII compounds of Ponceau Xylidine and Crystal Scarlet

The structures of seven divalent metal cation compounds of Ponceau Xylidine {PX; systematic name of dication: 4‐[2‐(3,4‐dimethylphenyl)hydrazin‐1‐ylidene]‐3‐oxo‐3,4‐dihydronaphthalene‐2,7‐disulfonate}, also known as Acid Red 26, CI 16150, and of five divalent metal cation compounds of Crystal Scarlet {CS; systematic name of dication: 8‐[2‐(naphthalen‐1‐yl)hydrazin‐1‐ylidene]‐7‐oxo‐7,8‐dihydronaphthalene‐1,3‐disulfonate}, also known as Acid Red 44, CI 16250, are presented. These are hexaaquamagnesium(II) PX dimethylformamide (DMF) monosolvate, [Mg(H₂O)₆](C₁₈H₁₄N₂O₇S₂)·C₃H₇NO, (I); heptaaquacalcium(II) PX 2.5‐hydrate, [Ca(H₂O)₇](C₁₈H₁₄N₂O₇S₂)·2.5H₂O, (II); catena‐poly[aqua(μ‐DMF)tris(DMF)bis(μ₃‐PX)distrontium(II)], [Sr(C₁₈H₁₄N₂O₇S₂)(C₃H₇NO)₂(H₂O)_0.5]_n, (III); the transition‐metal series hexaaquametal(II) PX DMF monosolvate, [M(H₂O)₆](C₁₈H₁₄N₂O₇S₂)·C₃H₇NO, where M (metal) = Co, (IV), Ni, (V), Cu, (VI), and Zn, (VII); heptaaquacalcium(II) CS monohydrate, [Ca(H₂O)₇](C₂₀H₁₃N₂O₇S₂)·H₂O, (VIII); octaaquastrontium(II) CS monohydrate, [Sr(H₂O)₈](C₂₀H₁₃N₂O₇S₂)·H₂O, (IX); catena‐poly[[triaqua(DMF)barium(II)]‐μ‐CS], [Ba(C₂₀H₁₃N₂O₇S₂)(C₃H₇NO)(H₂O)₃]_n, (X); tetrakis(DMF)(CS)copper(II) monohydrate, [Cu(C₂₀H₁₃N₂O₇S₂)(C₃H₇NO)₄]·H₂O, (XI); and catena‐poly[[[aquatris(DMF)zinc(III)]‐μ‐CS] diethyl ether hemisolvate], {[Zn(C₂₀H₁₃N₂O₇S₂)(C₃H₇NO)₃(H₂O)]·0.5C₄H₁₀O}_n, (XII). In all cases, the structures obtained were solvates with dimethylformamide (DMF) and/or water present. The disulfonated naphthalene‐based azo anions adopt hydrazone tautomeric forms. The structures of the Mg salt and of four transition‐metal forms (M = Co, Ni, Cu and Zn) of PX are found to form an isostructural series. All have solvent‐separated ion‐pair (SSIP) type structures and the formula [M(H₂O)₆][PX]·DMF. The Ca salt of PX also has an SSIP structure, but has a higher hydration state, [Ca(H₂O)₇][PX]·2.5H₂O. In contrast, the Sr salt of PX, [Sr(PX)(DMF)₂(H₂O)_0.5]_n forms a one‐dimensional coordination polymer. Both the Ca and the Sr salt of CS have an SSIP structure, namely [Ca(H₂O)₇][CS]·H₂O and [Sr(H₂O)₈][CS]·H₂O, whilst the heavier Ba analogue, [Ba(CS)(DMF)(H₂O)₃]_n, forms a one‐dimensional coordination polymer. Unlike PX, two CS structures containing transition metals are found to be coordination complexes, [Cu(CS)(DMF)₄]·H₂O and {[Zn(CS)(DMF)₃(H₂O)]·0.5Et₂O}_n. This suggests that CS is a better ligand than PX for transition metals. The Cu complex forms discrete molecules with Cu in a square‐pyramidal environment, whilst the Zn species is a one‐dimensional coordination polymer based on octahedral Zn centres.     

Four‐ and five‐coordinate copper(II) complexes with N‐(4,4‐diphenyl‐5‐oxo‐4,5‐dihydro‐1H‐imidazol‐2‐yl)glycine

The two title mononuclear compounds are four‐coordinate bis[N‐(5‐oxo‐4,4‐diphenyl‐4,5‐dihydro‐1H‐imidazolidin‐2‐ylidene)glycinato]copper(II) dimethylformamide disolvate, [Cu(C₁₇H₁₄N₃O₃)₂]·2C₃H₇NO, (I), and five‐coordinate aquabis[N‐(5‐oxo‐4,4‐diphenyl‐4,5‐dihydro‐1H‐imidazolidin‐2‐ylidene)glycinato]copper(II) dimethylformamide disolvate, [Cu(C₁₇H₁₄N₃O₃)₂(H₂O)]·2C₃H₇NO, (II). In (I), the Cu^II ion lies on an inversion centre with one‐half of the complex molecule in the asymmetric unit, while in (II) there are two independent ligand molecules in the asymmetric unit, with the Cu^II ion and coordinated water molecule located on a general position. In both crystal structures, the complex molecules assemble in ribbons via N—H...O hydrogen‐bond networks.     

Cocrystals of 6‐methyl‐2‐thiouracil: presence of the acceptor–donor–acceptor/donor–acceptor–donor synthon

The results of seven cocrystallization experiments of the antithyroid drug 6‐methyl‐2‐thiouracil (MTU), C₅H₆N₂OS, with 2,4‐diaminopyrimidine, 2,4,6‐triaminopyrimidine and 6‐amino‐3H‐isocytosine (viz. 2,6‐diamino‐3H‐pyrimidin‐4‐one) are reported. MTU features an ADA (A = acceptor and D = donor) hydrogen‐bonding site, while the three coformers show complementary DAD hydrogen‐bonding sites and therefore should be capable of forming an ADA/DAD N—H...O/N—H...N/N—H...S synthon with MTU. The experiments yielded one cocrystal and six cocrystal solvates, namely 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–1‐methylpyrrolidin‐2‐one (1/1/2), C₅H₆N₂OS·C₄H₆N₄·2C₅H₉NO, (I), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine (1/1), C₅H₆N₂OS·C₄H₆N₄, (II), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylacetamide (2/1/2), 2C₅H₆N₂OS·C₄H₆N₄·2C₄H₉NO, (III), 6‐methyl‐2‐thiouracil–2,4‐diaminopyrimidine–N,N‐dimethylformamide (2/1/2), C₅H₆N₂OS·0.5C₄H₆N₄·C₃H₇NO, (IV), 2,4,6‐triaminopyrimidinium 6‐methyl‐2‐thiouracilate–6‐methyl‐2‐thiouracil–N,N‐dimethylformamide (1/1/2), C₄H₈N₅⁺·C₅H₅N₂OS⁻·C₅H₆N₂OS·2C₃H₇NO, (V), 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–N,N‐dimethylformamide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₃H₇NO, (VI), and 6‐methyl‐2‐thiouracil–6‐amino‐3H‐isocytosine–dimethyl sulfoxide (1/1/1), C₅H₆N₂OS·C₄H₆N₄O·C₂H₆OS, (VII). Whereas in cocrystal (I) an R₂²(8) interaction similar to the Watson–Crick adenine/uracil base pair is formed and a two‐dimensional hydrogen‐bonding network is observed, the cocrystals (II)–(VII) contain the triply hydrogen‐bonded ADA/DAD N—H...O/N—H...N/N—H...S synthon and show a one‐dimensional hydrogen‐bonding network. Although 2,4‐diaminopyrimidine possesses only one DAD hydrogen‐bonding site, it is, due to orientational disorder, triply connected to two MTU molecules in (III) and (IV).     

Eight new crystal structures of 5‐(hydroxymethyl)uracil, 5‐carboxyuracil and 5‐carboxy‐2‐thiouracil: insights into the hydrogen‐bonded networks and the predominant conformations of the C5‐bound residues

In order to examine the preferred hydrogen‐bonding pattern of various uracil derivatives, namely 5‐(hydroxymethyl)uracil, 5‐carboxyuracil and 5‐carboxy‐2‐thiouracil, and for a conformational study, crystallization experiments yielded eight different structures: 5‐(hydroxymethyl)uracil, C₅H₆N₂O₃, (I), 5‐carboxyuracil–N,N‐dimethylformamide (1/1), C₅H₄N₂O₄·C₃H₇NO, (II), 5‐carboxyuracil–dimethyl sulfoxide (1/1), C₅H₄N₂O₄·C₂H₆OS, (III), 5‐carboxyuracil–N,N‐dimethylacetamide (1/1), C₅H₄N₂O₄·C₄H₉NO, (IV), 5‐carboxy‐2‐thiouracil–N,N‐dimethylformamide (1/1), C₅H₄N₂O₃S·C₃H₇NO, (V), 5‐carboxy‐2‐thiouracil–dimethyl sulfoxide (1/1), C₅H₄N₂O₃S·C₂H₆OS, (VI), 5‐carboxy‐2‐thiouracil–1,4‐dioxane (2/3), 2C₅H₄N₂O₃S·3C₆H₁₂O₃, (VII), and 5‐carboxy‐2‐thiouracil, C₁₀H₈N₄O₆S₂, (VIII). While the six solvated structures, i.e. (II)–(VII), contain intramolecular S(6) O—H…O hydrogen‐bond motifs between the carboxy and carbonyl groups, the usually favoured R₂²(8) pattern between two carboxy groups is formed in the solvent‐free structure, i.e. (VIII). Further R₂²(8) hydrogen‐bond motifs involving either two N—H…O or two N—H…S hydrogen bonds were observed in three crystal structures, namely (I), (IV) and (VIII). In all eight structures, the residue at the ring 5‐position shows a coplanar arrangement with respect to the pyrimidine ring which is in agreement with a search of the Cambridge Structural Database for six‐membered cyclic compounds containing a carboxy group. The search confirmed that coplanarity between the carboxy group and the cyclic residue is strongly favoured.     

Cocrystals of 2,6‐dichloroaniline and 2,6‐dichlorophenol plus three new pseudopolymorphs of their coformers

The structures of cocrystals of 2,6‐dichlorophenol with 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, C₆H₄Cl₂O·C₄H₇N₅, (III), and 2,6‐dichloroaniline with 2,6‐diaminopyrimidin‐4(3H)‐one and N,N‐dimethylacetamide, C₆H₅Cl₂N·C₄H₆N₄O·C₄H₉NO, (V), plus three new pseudopolymorphs of their coformers, namely 2,4‐diamino‐6‐methyl‐1,3,5‐triazine–N,N‐dimethylacetamide (1/1), C₄H₇N₅·C₄H₉NO, (I), 2,4‐diamino‐6‐methyl‐1,3,5‐triazine–N‐methylpyrrolidin‐2‐one (1/1), C₄H₇N₅·C₅H₉NO, (II), and 6‐aminoisocytosine–N‐methylpyrrolidin‐2‐one (1/1), C₄H₆N₄O·C₅H₉NO, (IV), are reported. Both 2,6‐dichlorophenol and 2,6‐dichloroaniline are capable of forming definite synthon motifs, which usually lead to either two‐ or three‐dimensional crystal‐packing arrangements. Thus, the two isomorphous pseudopolymorphs of 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, i.e. (I) and (II), form a three‐dimensional network, while the N‐methylpyrrolidin‐2‐one solvate of 6‐aminoisocytosine, i.e. (IV), displays two‐dimensional layers. On the basis of these results, attempts to cocrystallize 2,6‐dichlorophenol with 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, (III), and 2,6‐dichloroaniline with 6‐aminoisocytosine, (V), yielded two‐dimensional networks, whereby in cocrystal (III) the overall structure is a consequence of the interaction between the two compounds. By comparison, cocrystal–solvate (V) is mainly built by 6‐aminoisocytosine forming layers, with 2,6‐dichloroaniline and the solvent molecules arranged between the layers.     

Effect of Bulkiness on Reversible Substitution Reaction at MnII Center with Concomitant Movement of the Lattice DMF: Observation through Single‐Crystal to Single‐Crystal Fashion

The porous coordination polymer ({[Mn(L)H₂O](H₂O)_1.5(dmf)}_n, 1 ) (DMF=N,N‐dimethylformamide) exhibits variety of substitution reactions along with movement of lattice DMF molecule depending upon bulkiness of the external guest molecules. If pyridine or 4‐picoline is used as a guest, both lattice and coordinated solvent molecules are simultaneously substituted (complexes 6 and 7 , respectively). If a bulky guest like aniline is used, a partial substitution at the metal centers and full substitution at the channels takes place (complex 8 ). If the guest is 2‐picoline (by varying the position of bulky methyl group with respect to donor N atom), one Mn^II center is substituted by 2‐picoline, whereas the remaining center is substituted by a DMF molecule that migrates from the channel to the metal center (complex 9 ). Here, the lattice solvent molecules are substituted by 2‐picoline molecules. For the case of other bulky guests like benzonitrile or 2,6‐lutidine, both the metal centers are substituted by two DMF molecules, again migrating from the channel, and the lattice solvent molecules are substituted by these guest molecules (complex 10 and 11 , respectively). A preferential substitution of pyridine over benzonitrile (complex 12 ) at the metal centers is observed only when the molar ratio of PhCN:Py is 95:5 or less. For the case of an aliphatic dimethylaminoacetonitrile guest, the metal centers remain unsubstituted (complex 13 ); rather substitutions of the lattice solvents by the guest molecules take place. All these phenomena are observed through single crystal to single crystal (SC–SC) phenomena.     

Hirshfeld surface analysis of two bendroflumethiazide solvates

Bendroflumethiazide, or 3‐benzyl‐6‐(trifluoromethyl)‐3,4‐dihydro‐2H‐1,2,4‐benzothiadiazine‐7‐sulfonamide 1,1‐dioxide, is reported to crystallize as 1:1 solvates with acetone, C₁₅H₁₄F₃N₃O₄S₂·C₃H₆O, and N,N‐dimethylformamide, C₁₅H₁₄F₃N₃O₄S₂·C₃H₇NO. A detailed investigation of the crystal packing and intermolecular interactions is presented by means of Hirshfeld surface analysis. This analysis confirms the atomic positions of methyl H atoms of the solvent molecules that were inferred from the X‐ray data and provides a useful tool for structure validation.     

Synthesis,Characterization, and Properties of Four Metal Complexes with Mulitdentate N‐Acyl‐Salicylhydrazide Ligands

The reactions of the new nitrilotriacetic acid N′,N′,N′‐tri(salicyloyl)trihydrazide (Ntash) with the corresponding metal salts gave four new complexes [Pb₄(bshz)₂] · 2DMF ( 1 ), [Co₂(bshz)(C₅H₅N)₆] · 2ClO₄ · (C₅H₅N) · 2H₂O ( 2 ), [Cu₃(fshz)₂(C₅H₅N)₂] ( 3 ), and [Zn₃(fshz)₂(C₅H₅N)₃]_n · 2DMF ( 4 ), in which two multidentate ligands, namely N,N′‐disalicyloylhydrazine (H₄bshz) and N‐formylsalicylhydrazide (H₃fshz) were generated in situ from Ntash. The structures of these complexes were determined by single‐crystal X‐ray diffraction analysis. Complex 1 presents a novel tetranuclear lead(II) cluster structure with the four lead(II) cations in “hemidirected” coordination spheres. The neighboring tetranuclear clusters of 1 are connected by DMF molecules through weak Pb–O bonds, forming one‐dimensional ribbons. Complexes 2 and 3 show dinuclear and linear trinuclear structures with the corresponding Co^III and Cu^II ions in distorted octahedral and square‐planar coordination environments, respectively. Complex 4 exhibits a one‐dimensional zigzag chain structure. The magnetic properties of 3 and the photoluminescent properties of 4 were also investigated.     

Structural analysis of interpenetrated methyl‐modified MOF‐5 and its gas‐adsorption properties

The first example of an interpenetrated methyl‐modified MOF‐5 with the formula Zn₄O(DMBDC)₃(DMF)₂, where DMBDC^2? is 2,5‐dimethylbenzene‐1,4‐dicarboxylate and DMF is N,N‐dimethylformamide (henceforth denoted as Me₂MOF‐5‐int ), namely, poly[tris(μ₄‐2,5‐dimethylbenzene‐1,4‐dicarboxylato)bis(N,N‐dimethylformamide)‐μ₄‐oxido‐tetrazinc(II)], [Zn₄(C₁₀H₈O₄)₃O(C₃H₇NO)₂]_n, has been obtained from a solvothermal synthesis of 2,5‐dimethylbenzene‐1,4‐dicarboxylic acid and Zn(NO₃)₂·6H₂O in DMF. A systematic study revealed that the choice of solvent is of critical importance for the synthesis of phase‐pure Me₂MOF‐5‐int , which was thoroughly characterized by single‐crystal and powder X‐ray diffraction (PXRD), as well as by gas‐adsorption analyses. The Brunauer–Emmett–Teller surface area of Me₂MOF‐5‐int (660 m² g^?1), determined by N₂ adsorption, is much lower than that of nonpenetrated Me₂MOF‐5 (2420 m² g^?1). However, Me₂MOF‐5‐int displays an H₂ uptake capacity of 1.26 wt% at 77 K and 1.0 bar, which is comparable to that of non‐interpenetrated Me₂MOF‐5 (1.51 wt%).     

Aqua(phthalocyaninato‐κ4N)magnesium(II) 3‐chloropyridine disolvate

The structure of the title compound, [Mg(C₃₂H₁₆N₈)(H₂O)]·2C₅H₄ClN, comprises MgPcH₂O [Pc is phthalocyaninate(2−)] and 3‐chloropyridine solvent molecules interacting via O—H...N hydrogen bonds and π–π interactions. The central Mg atom is (4+1)‐coordinated by four equatorial isoindole N atoms of the macrocycle and by the O atom of an axial water molecule. The MgPcH₂O molecule is not planar, the Mg atom being displaced by 0.496 (2) Å from the isoindole N₄ plane towards the water O atom. MgPcH₂O molecules related by a twofold screw axis interact via O—H...N_azamethine hydrogen bonds, forming a polymeric chain along the b axis, while those related by inversion centres form π–π interacting dimers.     

A new one‐dimensional coordination polymer of 5‐(1,3‐dioxo‐4,5,6,7‐tetraphenylisoindolin‐2‐yl)isophthalic acid with manganese

The coordination polymer catena‐poly[[(dimethylformamide‐κO)[μ₃‐5‐(1,3‐dioxo‐4,5,6,7‐tetraphenylisoindolin‐2‐yl)isophthalato‐κ⁴O¹,O^1′:O³:O^3′](methanol‐κO)manganese(III)] dimethylformamide monosolvate], {[Mn(C₄₀H₂₃NO₆)(CH₃OH)(C₃H₇NO)]·C₃H₇NO}_n, has been synthesized from the reaction of 5‐(1,3‐dioxo‐4,5,6,7‐tetraphenylisoindolin‐2‐yl)isophthalic acid and manganese(II) acetate tetrahydrate in a glass tube at room temperature by solvent diffusion. The Mn^II centre is hexacoordinated by two O atoms from one chelating carboxylate group, by two O atoms from two monodentate carboxylate groups and by one O atom each from a methanol and a dimethylformamide (DMF) ligand. The single‐crystal structure crystallizes in the triclinic space group P. Moreover, the coordination polymer shows one‐dimensional 2‐connected {0} uninodal chain networks, and free DMF molecules are connected to the chains by O—H...O hydrogen bonds. The thermogravimetric and photoluminescent properties of the compound have also been investigated.